A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Pfizer Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 32,546 shares of PFE stock, worth $870,280. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,546
Previous 25,476 27.75%
Holding current value
$870,280
Previous $712,000 32.16%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $195,839 - $221,927
7,070 Added 27.75%
32,546 $941,000
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $207,485 - $243,134
-8,214 Reduced 24.38%
25,476 $712,000
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $693,541 - $796,407
-26,788 Reduced 44.29%
33,690 $934,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $12.1 Million - $15.7 Million
-462,443 Reduced 88.43%
60,478 $1.74 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $297,378 - $347,605
-9,267 Reduced 1.74%
522,921 $17.3 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $2.85 Million - $3.3 Million
78,965 Added 17.42%
532,188 $19.5 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $7.27 Million - $9.46 Million
184,535 Added 68.68%
453,223 $18.5 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $2.47 Million - $3.22 Million
-59,149 Reduced 18.04%
268,688 $13.8 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $298,399 - $364,270
6,819 Added 2.12%
327,837 $14.3 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $1.38 Million - $1.64 Million
29,725 Added 10.2%
321,018 $16.8 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $3.76 Million - $4.66 Million
-82,192 Reduced 22.01%
291,293 $15.1 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $6.56 Million - $9.72 Million
-158,691 Reduced 29.82%
373,485 $22.1 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $2.16 Million - $2.77 Million
54,946 Added 11.51%
532,176 $22.9 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $409,697 - $464,118
-11,409 Reduced 2.33%
477,230 $18.7 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $1.12 Million - $1.27 Million
-33,529 Reduced 6.42%
488,639 $17.7 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $407,664 - $518,380
12,180 Added 2.39%
522,168 $19.2 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $13.4 Million - $15.7 Million
-421,369 Reduced 45.24%
509,988 $18.7 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $2.39 Million - $2.9 Million
-79,258 Reduced 7.84%
931,357 $30.5 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $5.32 Million - $7.6 Million
196,870 Added 24.19%
1,010,615 $33 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $26.5 Million - $30.1 Million
805,654 Added 9957.41%
813,745 $31.9 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $13.1 Million - $17 Million
-403,692 Reduced 98.04%
8,091 $291,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $39.4 Million - $44.2 Million
-1,064,788 Reduced 72.11%
411,783 $17.8 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $33.1 Million - $36.3 Million
882,130 Added 148.4%
1,476,571 $62.7 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $5.42 Million - $6.18 Million
140,800 Added 31.04%
594,441 $25.9 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $28.3 Million - $34.3 Million
-819,658 Reduced 64.37%
453,641 $20 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $4.64 Million - $4.95 Million
-140,811 Reduced 9.96%
1,273,299 $46.2 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $43.5 Million - $50.5 Million
1,364,188 Added 2732.64%
1,414,110 $50.2 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $934,772 - $991,825
28,105 Added 128.82%
49,922 $1.81 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $676,327 - $745,050
21,817
21,817 $779,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.